Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

STREPTOMYCIN THERAPY IN PULMONARY TUBERCULOSIS

STREPTOMYCIN THERAPY IN PULMONARY TUBERCULOSIS Abstract Riggins and Hinshaw1 have summarized the results of the use of streptomycin in 332 patients with pulmonary tuberculosis; patients were treated by cooperative investigators designated by the executive committee of the American Trudeau Society. A statistical analysis was made on those who had been observed for at least ninety days after initiation of treatment. Types differing as to nature of disease, age, race and sex were treated in widely separated sections of the country. Of the 332 patients with pulmonary tuberculosis, 17 had minimal, 118 moderately advanced and 197 far advanced disease; 80 per cent had predominantly acute or subacute disease, and the remainder predominantly chronic disease at the beginning of the treatment. The beneficial effect of streptomycin in tuberculosis, the report indicates, depends on its interference with the growth and multiplication of streptomycin-sensitive strains of Mycobacterium tuberculosis. Streptomycin apparently does not directly enhance repair to tissue, but it References 1. Riggins, H. M., and Hinshaw, H. C.: Streptomycin-Tuberculosis Research Project of the American Trudeau Society: A Summary Report . Am. Rev. Tuberc. 59:140-167 ( (Feb.) ) 1949. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

STREPTOMYCIN THERAPY IN PULMONARY TUBERCULOSIS

JAMA , Volume 140 (10) – Jul 9, 1949

Loading next page...
 
/lp/american-medical-association/streptomycin-therapy-in-pulmonary-tuberculosis-0cIMZVA8kY

References (1)

Publisher
American Medical Association
Copyright
Copyright © 1949 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1949.02900450026009
Publisher site
See Article on Publisher Site

Abstract

Abstract Riggins and Hinshaw1 have summarized the results of the use of streptomycin in 332 patients with pulmonary tuberculosis; patients were treated by cooperative investigators designated by the executive committee of the American Trudeau Society. A statistical analysis was made on those who had been observed for at least ninety days after initiation of treatment. Types differing as to nature of disease, age, race and sex were treated in widely separated sections of the country. Of the 332 patients with pulmonary tuberculosis, 17 had minimal, 118 moderately advanced and 197 far advanced disease; 80 per cent had predominantly acute or subacute disease, and the remainder predominantly chronic disease at the beginning of the treatment. The beneficial effect of streptomycin in tuberculosis, the report indicates, depends on its interference with the growth and multiplication of streptomycin-sensitive strains of Mycobacterium tuberculosis. Streptomycin apparently does not directly enhance repair to tissue, but it References 1. Riggins, H. M., and Hinshaw, H. C.: Streptomycin-Tuberculosis Research Project of the American Trudeau Society: A Summary Report . Am. Rev. Tuberc. 59:140-167 ( (Feb.) ) 1949.

Journal

JAMAAmerican Medical Association

Published: Jul 9, 1949

There are no references for this article.